NEW YORK, Sept. 30, 2024 /PRNewswire/ -- Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against:Akero Therapeutics, Inc. ("Akero") (NASDAQ:AKRO)Shareholders should email [email protected]; please contact only if shares acquired before September 13, 2022The investigation concerns misrepresentations to investors as to the true nature of the patient population that was being tested in Akero's SYMMETRY study. Specifically, despite telling investors t ...